Soleno Therapeutics, Inc. (SLNO)
Soleno Therapeutics, Inc. is a clinical-stage biotech company focused on rare diseases. Its lead candidate, diazoxide choline extended-release (DCCR), targets Prader-Willi syndrome. Growth is driven by potential FDA approval, expanded indications, and high unmet medical needs in orphan drug markets. Chart
Brinker International, Inc. (EAT)
Brinker International, Inc. owns and operates popular restaurant chains including Chili’s and Maggiano’s. With a focus on casual dining, the company leverages brand recognition, operational efficiency, and digital ordering. Growth is fueled by traffic recovery, menu innovation, and global expansion. Chart
